Pen Yan Jing Tablets Alleviates Pelvic Inflammatory Disease by Inhibiting Akt/NF-κB Pathway
International Journal of Medical Sciences · 2023
DOI: 10.7150/ijms.87433 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2023. Verfasst von Ping Tang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Center, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. Hauptthemen laut MEDLINE: NF-kappa B, Pelvic Inflammatory Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Experimental Center, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
- Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Co., Ltd., Guangzhou, 510515, China.
- School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Zitieren
APA
Tang, P., Ding, Q., Lin, J., Yang, X., Wang, Y., Liu, F., Zheng, Y., Lin, L., Wang, D., & Lin, B. (2023). Pen Yan Jing Tablets Alleviates Pelvic Inflammatory Disease by Inhibiting Akt/NF-κB Pathway. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.87433
Vancouver
Tang P, Ding Q, Lin J, Yang X, Wang Y, Liu F, et al. Pen Yan Jing Tablets Alleviates Pelvic Inflammatory Disease by Inhibiting Akt/NF-κB Pathway. International Journal of Medical Sciences. 2023. doi:10.7150/ijms.87433
BibTeX
@article{Tang2023,
author = {Tang, Ping and Ding, Qi and Lin, Juan and Yang, Xinrong and Wang, Yiting and Liu, Fangle and Zheng, Yuying and Lin, Liuqing and Wang, Deqin and Lin, Baoqin},
title = {Pen Yan Jing Tablets Alleviates Pelvic Inflammatory Disease by Inhibiting Akt/NF-κB Pathway},
journal = {International Journal of Medical Sciences},
year = {2023},
doi = {10.7150/ijms.87433}
}
EUVIMED